NEUMOSUIN, ενέσιμο εναιώρημα για χοίρους
NEUMOSUIN, ενέσιμο εναιώρημα για χοίρους
Authorised
- Pasteurella multocida, strain 1231, Inactivated
- Actinobacillus pleuropneumoniae, serovar 5, strain WSLB 3079, Inactivated
- Actinobacillus pleuropneumoniae, serovar 2, strain B4, Inactivated
Product identification
Medicine name:
NEUMOSUIN, ενέσιμο εναιώρημα για χοίρους
Active substance:
- Pasteurella multocida, strain 1231, Inactivated
- Actinobacillus pleuropneumoniae, serovar 5, strain WSLB 3079, Inactivated
- Actinobacillus pleuropneumoniae, serovar 2, strain B4, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Pasteurella multocida, strain 1231, Inactivated800000000.00/cells1.00Dose
-
Actinobacillus pleuropneumoniae, serovar 5, strain WSLB 3079, Inactivated4000000000.00/cells1.00Dose
-
Actinobacillus pleuropneumoniae, serovar 2, strain B4, Inactivated8000000000.00/cells1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal21day
-
-
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 24503/03-04-2009/K-0073101
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
